A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect
Abstract Background RAD51C is important in DNA repair and individuals with pathogenic RAD51C variants have increased risk of hereditary breast and ovarian cancer syndrome (HBOC), an autosomal dominant genetic predisposition to early onset breast and/or ovarian cancer. Methods Five female HBOC proban...
Main Authors: | Lesa M. Dawson, Kerri N. Smith, Salem Werdyani, Robyn Ndikumana, Cindy Penney, Louisa L. Wiede, Kendra L. Smith, Justin A. Pater, Andrée MacMillan, Jane Green, Sheila Drover, Terry‐Lynn Young, Darren D. O’Rielly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1070 |
Similar Items
-
The <i>BRCA1</i> c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times
by: Paolo Aretini, et al.
Published: (2023-10-01) -
Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia
by: Rosado-Jiménez Laura, et al.
Published: (2023-09-01) -
A Novel Homozygous Founder Variant of <i>RTN4IP1</i> in Two Consanguineous Saudi Families
by: Mazhor Aldosary, et al.
Published: (2022-10-01) -
A Founder Pathogenic Variant of PPIB Unique to Chinese Population Causes Osteogenesis Imperfecta IX
by: Wenting Zhu, et al.
Published: (2021-09-01) -
Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing
by: Stattin Eva-Lena, et al.
Published: (2012-10-01)